JoannaYiMD

PubMed

• 8 citations
  Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
  Susan N Chi, Joanna S Yi, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Brent D Coffey, Joel M Reid, Jin Piao, Lauren Saguilig, Todd A Alonzo, Stacey L Be...> ;Journal of the National Cancer Institute. 2023 Nov 8
• 6 citations
  Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.
  Adriana Trabal, Amber Gibson, Jiasen He, David McCall, Michael Roth, Cesar Nuñez, Miriam Garcia, Meredith Buzbee, Laurie Toepfer, Aram Bidikian, Naval Daver, Tapan Kad...> ;Cancers. 2023 Mar 26
• 1 citations
  Novel CIC variants identified in individuals with neurodevelopmental phenotypes.
  Saloni Sharma, Brenna Hourigan, Zain Patel, Jill A Rosenfeld, Katie M Chan, Michael F Wangler, Joanna S Yi, Anna Lehman, , Gabriella Horvath, Paul A Cloos, Qiumin Tan> ;Human Mutation. 2022 Jul 1
• 5 citations
  A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment.
  Joanna S Yi, Tiffany M Chambers, Kelly D Getz, Tamara P Miller, Evanette Burrows, Marla H Daves, Philip J Lupo, Michael E Scheurer, Richard Aplenc, Karen R Rabin, Mari...> ;Haematologica. 2022 May 1
• 34 citations
  Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol...
  Maureen M O'Brien, Lingyun Ji, Nirali N Shah, Susan R Rheingold, Deepa Bhojwani, Constance M Yuan, Xinxin Xu, Joanna S Yi, Andrew C Harris, Patrick A Brown, Michael J ...> ;Journal of Clinical Oncology. 2022 Mar 20
• 7 citations
  An oncogenic enhancer encodes selective selenium dependency in AML.
  Kenneth Eagle, Yajian Jiang, Xiangguo Shi, Minhua Li, Nikolaus P Obholzer, Tianyuan Hu, Monika W Perez, Jošt Vrabič Koren, Ayumi Kitano, Joanna S Yi, Charles Y Lin, Da...> ;Cell Stem Cell. 2022 Mar 3
• 7 citations
  The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
  Joanna S. Yi, Oscar Sias-Garcia, Nicole Nasholm, Xiaoyu Hu, Amanda Balboni Iniguez, Matthew D. Hall, Mindy I. Davis, Rajarshi Guha, Myrthala Moreno-Smith, Eveline Barb...> ;Neoplasia. 2021 Jun 6
• 38 citations
  ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
  Amir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, Hsiao-Chi Chen, Selin Jessa, Bryan Rivas, Austin J. Stuckert, Minerva Solis, Alisha Kardian, Dana Tlais, Brian Golbo...> ;Cancer Discovery. 2021 Mar 19
• 1 citations
  Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan
  Joanna S. Yi, Junne Kamihara, Jennifer C. Kesselheim, Kimberly Davies, Jack van Hoff, Lewis B. Silverman, Elizabeth Mullen> ;Pediatric Blood & Cancer. 2017 May 1
• 20 citations
  Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.
  Shayahati Bieerkehazhi, Zhenghu Chen, Yanling Zhao, Yang Yu, Huiyuan Zhang, Sanjeev A. Vasudevan, Sarah E. Woodfield, Ling Tao, Joanna S. Yi, Jodi A. Muscal, Jonathan ...> ;Oncotarget. 2017 Jan 3
• 8 citations
  A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients
  Adam L. Green, Joanna Yi, Natalie Susan Bezler, Yana Pikman, Venée N. Tubman, Esther A. Obeng, Teresa O'Neil, Robert Mersereau, Lisa Morrissey, Amy L. Billett> ;Pediatric Blood & Cancer. 2016 Jan 1
• 16 citations
  Structure-guided DOT1L probe optimization by label-free ligand displacement.
  Joanna S. Yi, Alexander J. Federation, Jun Qi, Sirano Dhe-Paganon, Michael Hadler, Xiang Xu, Roodolph St. Pierre, Anthony C. Varca, Lei Wu, Jason J. Marineau, William ...> ;ACS Chemical Biology. 2014 Dec 3
• Join now to see all

Abstracts/Posters

• A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...
  Joanna S. Yi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Rara Is a Druggable Super-Enhancer Regulated Dependency in Pediatric AML
  Joanna S. Yi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• An Oncogenic Enhancer Encodes Selective Selenium Dependency in AML
  Joanna S. Yi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Pa... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019